Microchip Technology Incorporated MCHP
Verdict: Hold. Fair value $70.02 against a price of $67.06 on 6 Jan 2026, 4% above the price.
In plain words
The case for: Narrow competitive moat provides durability. Industry tailwinds with growing market.
The case against: Intense competitive pressure could compress margins.
Main risks
- Collapsing Revenue and Profitability: TTM revenue has declined ~45% from the prior fiscal year, with forward estimates pointing to zero net income, indicating a severe cyclical downturn.
- Dangerously High Leverage: Net Debt to TTM EBITDA is estimated at ~6.4x. This level of debt is a major risk for a cyclical company, severely constraining financial flexibility and amplifying the impact of the downturn.
- Value-Destructive Recent Capital Allocation: TTM ROIC of ~4.8% is well below WACC. The estimated 2-year ROIIC is deeply negative (-84.6%), suggesting that capital invested over the past two years has coincided with a dramatic collapse in profitability.
- Near-term debt maturity concerns
- Low interest coverage (2.7x)
- Intense competitive environment